BIONTECH

Brazil is among the worst affected countries in the world by the Covid pandemic, with more than 600,000 victims. But what if everyone without exception is vaccinated? Pfizer began such an experiment in the city of Toledo.

The United States on Oct. 29 authorized the Pfizer Covid vaccine for children aged five-to-11, paving the way for 28 million young Americans to soon get immunized.

The Turkish Health Ministry's Science Board will look into whether the COVID-19 vaccine could be administered to children aged between 5 and 11 after the U.S. Food and Drug Administration's (FDA) Advisory Committee recommended the Pfizer/BioNTech jab for this age group.

The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers on Oct. 26 endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds.

The number of daily booster shots given in Turkey is still too low, while the pace of inoculations for the first dose has also lost steam, an expert has warned.

As of Saturday, the United States had administered 412,856,169 doses of COVID-19 vaccines and sent 503,521,625 doses to vaccination centers, the U.S. Centers for Disease Control and Prevention said.

The interest in vaccination in our country continues to increase. Another day with queues for immunization in the country. Vaccination points in Ruse even warn that there is already a shortage of some vaccines.

The executive drug agency reassured that there were enough doses available from the 4 authorized vaccines.

Young people are appearing to be the main culprit for the spread of COVID-19 recently, Health Minister Fahrettin Koca has said, noting that, however, most of the patients who are treated for the coronavirus in intensive care units are the elderly and those with chronic diseases. 

Some 5 million people who have already received two doses of the inactivated COVID-19 vaccines have skipped their third shot, Health Minister Fahrettin Koca has said, urging them to get the booster shot as soon as possible.

Turkey is presently using both the mRNA vaccine developed by Pfizer/BioNTech and the Chinese company Sinovac's inactivated vaccine in its inoculation drive.

The European Medicines Agency (EMA) has announced that it will analyze data, including the results from an ongoing study, for a vaccine distributed under the name "Comirnaty". It is already approved for children older than 12 in the USA and the EU.